ClinicalTrials.Veeva

Menu

Promoting the Use of CPAP Therapy Among OSA Patients

S

Sarah Alismail

Status

Completed

Conditions

Obstructive Sleep Apnea

Treatments

Behavioral: CPAP4HealthySleep system

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Obstructive sleep apnea (OSA) is the most common sleep breathing disorder in the U.S. Continuous Positive Airway Pressure (CPAP) therapy is the most effective treatment for OSA. However, up to 50% of patients who accept using CPAP therapy fail to adhere to it. This study will evaluate an information systems (IS)-based solution that sends tailored, motivational, educational messages and tailored feedback messages to promote CPAP usage among noncompliant OSA patients. The primary aim of this study is to determine the efficacy of the proposed IS solution and its effect on fostering the use of CPAP therapy among OSA patients.

Enrollment

59 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of OSA
  • Prescribed treatment of CPAP therapy
  • Possession of a mobile phone that has multimedia messaging capabilities
  • Capacity to consent.

Exclusion criteria

  • Unable to speak and read English

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

59 participants in 2 patient groups

CPAP4HealthySleep: System 1 (ABAB)
Experimental group
Description:
Participants in this group will first receive six tailored educational messages per week and weekly feedback messages notifying participants of their CPAP usage on the seventh day for two weeks (type A). Next, they will receive weekly feedback messages only (one message per week) notifying participants of their CPAP usage for two weeks (type B), re-introduction of type A for another two weeks, followed by re-introduction of type B for two weeks.
Treatment:
Behavioral: CPAP4HealthySleep system
CPAP4HealthySleep: System 2 (BABA)
Experimental group
Description:
Participants in this group will first receive weekly feedback messages only (one message per week) notifying participants of their CPAP usage for two weeks (type B). Next, they will receive six tailored educational messages per week and weekly feedback messages notifying participants of their CPAP usage on the seventh day for two weeks (type A), re-introduction of type B for another two weeks, followed by re-introduction of type A for two weeks.
Treatment:
Behavioral: CPAP4HealthySleep system

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems